IRCT20191005044984N1招募中3 期
Comparing efficacy of dolutegravir plus tenofovir alafenamide as dual-drug regimen with the standard triple-drug regimen in HIV positive patients
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Adults older than 18 years old
- •HIV positive patients with undetectable viral load for at least 2 years
- •HIV positive patients with CD4 cells count >200 for at least 2 years
- •Patients who are on first line antiretroviral therapy for at least 2 years
- •No any mutation against INSTI or NRTI drugs
- •Adequate adherence to treatment
- •No any AIDS-related event (opportunistic infection or cancer)
排除标准
- •Pregnancy and lactation
- •Concomitant viral co-infections including hepatitis B or C
- •Existing any co-morbidity that requiring treatment which may have significant interactions with ART
- •Renal or hepatic diseases
研究者
相似试验
已完成
2 期
Clinical trial study on the therapeutic effect of Tenofovir besides routine drug regime (standard of care) in patients with Coronavirus disease 2019 (COVID-19)covid-19.Covid-19, confirmed cases, positive test resultU07.1IRCT20200422047168N1Ahvaz University of Medical Sciences60
已完成
4 期
Effectiveness and Safety of Tenofovir + Lamivudine + Efavirenz Generic Scheme for the Treatment of HIV Infection / AIDS in Patients of the CLS,Colombia, 2012-2013.HIV/AIDSRPCEC00000134Corporación de Lucha Contra el Sida80
已完成
4 期
Dolutegravir Plus Tenofovir/Lamivudine or Emtricitabine in HIV-1 Infected Transgender WomenHIV InfectionsNCT03033836Fundación Huésped60
已完成
3 期
An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir Plus Lamivudine With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Subjects (Gemini 1)Infection, Human Immunodeficiency VirusHIV InfectionsNCT02831673ViiV Healthcare719
已完成
3 期
An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir (DTG) Plus Lamivudine (3TC) With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Participants (Gemini 2)Infection, Human Immunodeficiency VirusHIV InfectionsNCT02831764ViiV Healthcare722